The exhaustion that comes with heavy perimenopausal bleeding is so layered — it's the blood loss, the broken sleep, the hormonal chaos — that anemia can hide inside all of it for years. What stands out most is how often women are told their tiredness is 'just perimenopause' without a single ferritin level ever being checked. That one missed test can mean the difference between feeling functional and feeling like you're disappearing.
Learn more about Rose →Anovulatory cycles — cycles without ovulation — are common in perimenopause and produce an unopposed estrogen environment that causes the uterine lining to build up thicker than usual, resulting in heavier, longer, and more unpredictable bleeds. Blood loss exceeding 80ml per cycle is classified as heavy menstrual bleeding, but research shows women consistently underestimate their own blood loss, and clinicians rarely quantify it. This means a woman losing the equivalent of a small hemorrhage every few weeks may not trigger the clinical concern her blood volume actually warrants.
A complete blood count (CBC) can appear within normal range until anemia is already well established, because hemoglobin and hematocrit are late-stage indicators of iron depletion. Ferritin, the protein that stores iron in cells, drops long before hemoglobin falls, making it the earliest and most sensitive marker of iron deficiency — but it is not included in a standard CBC and must be specifically requested. A woman can have a ferritin level of 8 ng/mL, be functionally iron-depleted, and receive a CBC result that looks completely normal to both her and her doctor.
Iron deficiency impairs the synthesis of dopamine, serotonin, and norepinephrine — neurotransmitters directly involved in mood, motivation, and cognitive sharpness — producing symptoms that are nearly indistinguishable from the hormonal symptom profile of perimenopause itself. A woman presenting with fatigue, difficulty concentrating, low mood, and poor sleep is very likely to receive a conversation about estrogen and progesterone without anyone considering that her iron stores may be critically low. This diagnostic overlap is not theoretical; studies of women with heavy menstrual bleeding consistently show underdiagnosis of iron deficiency anemia in primary care settings.
Serum iron — the amount of iron currently circulating in the blood — fluctuates significantly throughout a single day, rises after meals, and is affected by inflammation, infection, and even recent exercise, making it a poor standalone diagnostic tool. When serum iron is ordered instead of ferritin, it can return a normal or even elevated result in a woman who has severely depleted iron stores, because the body redirects available iron into circulation as a compensatory response. The more complete and meaningful panel for a perimenopausal woman with heavy bleeding includes ferritin, serum iron, transferrin saturation, and TIBC (total iron-binding capacity) together.
Standard laboratory reference ranges for ferritin often list anything above 12–15 ng/mL as 'normal,' but functional medicine research and growing clinical evidence suggest that symptoms of iron deficiency — including fatigue, hair loss, restless legs, and poor concentration — frequently persist until ferritin reaches 50–70 ng/mL or higher. A woman with a ferritin of 14 ng/mL may be told her iron is fine while experiencing textbook iron-deficiency symptoms, simply because her result sits technically above the laboratory floor. The reference range issue is particularly relevant in perimenopause, where symptoms are already attributed to hormones rather than prompting further investigation.
Ferritin is an acute-phase reactant, meaning that inflammation — including the low-grade chronic inflammation that rises with hormonal fluctuation in perimenopause — causes the liver to release more ferritin into the bloodstream regardless of actual iron stores. This means a woman with genuinely depleted iron reserves can present with a ferritin level that appears adequate or even elevated on paper, creating a false sense of security for both patient and clinician. When inflammatory markers like CRP (C-reactive protein) are elevated, ferritin results must be interpreted with that context in mind, and transferrin saturation becomes a more reliable indicator.
After menopause, when monthly blood loss stops, the body's primary iron-excretion mechanism disappears — and iron begins to accumulate in tissues, which is associated with increased cardiovascular and metabolic risk in postmenopausal women. The diagnostic challenge is that perimenopause is a liminal stage: a woman may be losing significant iron through heavy bleeding one year and accumulating excess iron two years later, with no obvious clinical marker indicating the shift has occurred. Without tracking ferritin across the transition, clinicians may continue treating for deficiency when the clinical picture has quietly reversed.
Restless leg syndrome (RLS) — the uncomfortable urge to move the legs, especially at night — has a well-established association with low iron stores, and low ferritin is considered a treatable contributing cause in a significant proportion of RLS cases. Pica, the craving to consume non-food items like ice, clay, or starch, is a classical but often unrecognized symptom of iron deficiency that women in midlife may feel embarrassed to mention. Both of these symptoms are frequently attributed to aging, anxiety, or sleep disruption in perimenopausal women rather than triggering an iron panel.
For accurate iron status assessment in a perimenopausal woman with heavy bleeding, the evidence-informed panel includes: full blood count (CBC), ferritin, serum iron, TIBC, transferrin saturation, and CRP or ESR to contextualize ferritin if inflammation is suspected. Thyroid function (TSH, free T4) should be included because hypothyroidism both worsens heavy bleeding and causes its own fatigue and cognitive symptoms, compounding the diagnostic confusion. Vitamin B12 and folate are also worth checking, since B12 deficiency produces a macrocytic anemia that can coexist with or mask iron-deficiency anemia and is itself more common as absorption changes with age.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.